🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8760
-0.4340 (-33.13%)
At close: Nov 20, 2026, 4:00 PM EST
0.8620
-0.0140 (-1.60%)
After-hours: Nov 20, 2026, 7:40 PM EST

PMV Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
15.3116.3320.924.2525.0521.8
Research & Development
61.969.8857.9355.8951.9936.49
Operating Expenses
77.2186.2178.8380.1377.0458.29
Operating Income
-77.21-86.21-78.83-80.13-77.04-58.29
Interest & Investment Income
3.836.3410.6611.173.630.45
Other Non Operating Income (Expenses)
-15.14-0.05-0.0200.090.02
EBT Excluding Unusual Items
-88.51-79.91-68.19-68.96-73.33-57.82
Merger & Restructuring Charges
---0.6---
Asset Writedown
---6.02---
Pretax Income
-88.51-79.91-74.81-68.96-73.33-57.82
Income Tax Expense
0.02-2.17-16.10-0.010.02
Net Income
-88.53-77.74-58.71-68.96-73.32-57.85
Net Income to Common
-88.53-77.74-58.71-68.96-73.32-57.85
Net Income Growth
------
Shares Outstanding (Basic)
575352484645
Shares Outstanding (Diluted)
575352484645
Shares Change
8.38%1.87%7.42%5.31%1.01%214.23%
EPS (Basic)
-1.56-1.48-1.14-1.44-1.61-1.28
EPS (Diluted)
-1.56-1.48-1.14-1.44-1.61-1.28
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-69.64-73.61-51.94-56.62-71.74-47.92
Free Cash Flow Per Share
-1.23-1.40-1.01-1.18-1.57-1.06
EBITDA
-77.09-86.07-77.68-78.88-76.73-57.99
D&A For EBITDA
0.110.131.141.260.320.31
EBIT
-77.21-86.21-78.83-80.13-77.04-58.29
SEC Filings: 10-K · 10-Q